semaglutide and blindness A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic & Blindness: What the

Big Pharma finally flinched on insulin pricing

Understanding the reason youre switching can help ensure a smoother transition and better support your health goals

Most shedding is temporary linked to nutrient shifts, metabolic stress, or rapid weight changes

The glucagon-like peptide 1 (GLP-1) analogue, Exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors

At a certain price point, insurance will cover the drug for people who are most at risk of health problems

There are currently 5-10 million people on a branded GLP-1 medication, but there is an estimated 50-60 million who are clinically eligible to receive Wegovy and have insurance coverage for it, and of those, millions could purchase it for a copay of less than $100/month